KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Hematology / 2021 / Cilt: 38 - Sayı: 2

lginç Bir Olgu: Sunutinib İlişkili Mikroanjiyopatik Hemolitik Anemi ve Nefrotik Sendrom

An Interesting Case: Sunitinib-Induced Microangiopathic Hemolytic Anemia and Nephrotic Syndrome

Semra Paydaş
Veysel Haksöyler
Sayfa
163–165
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

Paydaş, S., Haksöyler, V. (2022). lginç Bir Olgu: Sunutinib İlişkili Mikroanjiyopatik Hemolitik Anemi ve Nefrotik Sendrom. Turkish Journal of Hematology, Cilt: 38 - Sayı: 2, 163–165. https://ajindex.com/articles/606545

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Faivre S, Delbaldo C, Vera K, Robert C, Lozahic S, Lassau N, Bello C, Deprimo S, Brega N, Massimini G, Armand JP, Scigalla P, Raymond E. Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol 2005;24:25-35
  2. Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 2000;58:2390- 2399. Maroeska Te Loo D, Bosma N, Van Hinsbergh V, Span P, De Waal R, Clarijs R, Sweep C, Monnens L, Van Den Heuvel L. Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS. Pediatr Nephrol 2004;19:754-760
  3. Kamba T, McDonald DM. Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 2007;96:1788-1795
  4. Bollée G, Patey N, Cazajous G, Robert C, Goujon JM, Fakhouri F, Bruneval P, Noël LH, Knebelmann B. Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib. Nephrol Dial Transplant 2009;24:682-685
  5. Costero O, Picazo ML, Zamora P, Romero S, Martinez-Ara J, Selgas R. Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy. Nephrol Dial Transplant 2010;25:1001
  6. Noronha V, Punatar S, Joshi A, Desphande RV, Prabhash K. Sunitinib- induced thrombotic microangiopathy. J Cancer Res Ther 2016;12:6-11
  7. Kapiteijn E, Brand A, Kroep J, Gelderblom H. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome. Ann Oncol 2007;18:1745-1747
  8. Jha PK, Vankalakunti M, Siddini V, Bonu R, Prakash GK, Babu K, Ballal HS. Sunitinib induced nephrotic syndrome and thrombotic microangiopathy. Indian J Nephrol 2013;23:67-70
  9. Choi MK, Hong JY, Jang JH, Lim HY. TTP-HUS associated with sunitinib. Cancer Res Treat 2008;40:211-215